News

No Increased Cancer Risk Seen in Stem Cell, Marrow Donors

Publish date: January 7, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY

The authors said they had no relevant conflicts of interest.

Pages

Recommended Reading

Iniparib Extends Triple-Negative Breast Cancer Survival Nearly 5 Months
MDedge Internal Medicine
Isolated Pelvic Chemoperfusion Can Benefit Advanced Abdominal Cancers
MDedge Internal Medicine
In Good-Risk Breast Cancer, Longer Chemotherapy Isn't Better
MDedge Internal Medicine
Alemtuzumab Reduces Minimal Residual Disease in CLL Patients
MDedge Internal Medicine
Seroma After Breast Cancer Surgery Triples Lymphedema Risk
MDedge Internal Medicine
Bevacizumab Maintenance Extends Lung Cancer Survival in Community Practice
MDedge Internal Medicine
Romidepsin Induces Complete Response in Peripheral T-Cell Lymphoma
MDedge Internal Medicine
Young Adult AML Patients Fare Better on Children's Protocol
MDedge Internal Medicine
Liposomal Cytarabine-Daunorubicin Improves AML Remission Rates
MDedge Internal Medicine
Chemotherapy Sequence Affects Early Breast Cancer Outcomes
MDedge Internal Medicine